Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
A settlement being discussed in a lawsuit against the NCAA and major college conferences could cost billions and pave the way for a compensation model.
As inflation-weary consumers cut back on dining out, brands like McDonald’s are relying more heavily on celebrity and influencer endorsements to move the needle